REISTONE BIOPHARMA Trademark
Trademark Overview
On Monday, May 10, 2021, a trademark application was filed for REISTONE BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the REISTONE BIOPHARMA trademark a serial number of 90701089. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Reistone Biopharma Inc.. The REISTONE BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biochemical research and development; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research in the field of pharmaceuticals
General Information
| Serial Number | 90701089 |
| Word Mark | REISTONE BIOPHARMA |
| Filing Date | Monday, May 10, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 24, 2022 |
| Registration Number | 6728700 |
| Registration Date | Tuesday, May 24, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 1, 2022 |
Trademark Statements
| Description of Mark | The mark consists of The words "Reistone" and "Biopharma" in a custom designed font, separated by a bold line, with Reistone positioned above the bold line and Biopharma positioned below the bold line. |
| Disclaimer with Predetermined Text | "BIOPHARMA" |
| Goods and Services | Biochemical research and development; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research in the field of pharmaceuticals |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 10, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, December 3, 2018 |
| First Use In Commerce Date | Monday, December 3, 2018 |
Trademark Owner History
| Party Name | Reistone Biopharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Rosemont, IL 60018 |
| Party Name | Reistone Biopharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02111 |
| Party Name | Reistone Biopharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02111 |
Trademark Events
| Event Date | Event Description |
| Monday, July 18, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, July 18, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 18, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, July 18, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, July 18, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 24, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 24, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 1, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 9, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 21, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 13, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, August 11, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, August 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 13, 2021 | NEW APPLICATION ENTERED IN TRAM |
